Lexington Biosciences (LXGTF) Financial Statements

Lexington Biosciences's market cap is currently $219.86K. The company's EPS TTM is $; its P/E ratio is ―; Lexington Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.